The COVID-19 pandemic has accelerated Government adoption of plans to implement the digitization of healthcare and the use of technology to store, share, and analyze healthcare information.
COVID-19 Pandemic Accelerated Demand for Hospitals and Clinical Labs: COVID-19 pandemic had a lot to do with the increased demand for hospitals. The shortage of hospitals led to the establishment of makeshift clinics and health centers around the world, and a similar situation had been found in Malaysia. The pandemic had shown the inability of various countries, including Malaysia, to cope with the pandemic situation, thereby increasing the need for hospital construction, further supporting the growth of the market in forthcoming years.
Genetic Testing: Growing interest in genetic testing is also driving the market. Genetic testing helps patients make important decisions about treatment and early detection of genetic problems. The high prevalence of refractory diseases in Malaysia, coupled with growing awareness of the importance of early diagnosis and accuracy of laboratory analysis, has led to an increase in patient visits to diagnostic laboratories for testing.
Adoption of Digital Pathology: Increased adoption of digital pathology has further increased the demand for clinical laboratory services. High prevalence of infectious diseases across Malaysia and growing awareness of early and accurate diagnosis are expected to drive the expansion of the clinical laboratory services market.
Government Initiatives: Investment by the government in multiple sectors and “My Health” by MOH are the government initiatives taken for the healthcare sector in Malaysia. A-Bio has raised a major revenue in funding at Clinipath Malaysia Sdn. Bhd. (Clinipass), promoting the digitalization of the medical industry in Malaysia.
Analysts at Ken Research in their latest publication “Malaysia Clinical Lab Market Outlook to 2027F- Medical tourism and government investment is driving the future of healthcare and clinical Tests in Malaysia” by Ken Research observed that Malaysia clinical lab market is in the growing phase. Growing medical infrastructure, increasing number of hospitals, and medical tourism are some of the factors that will contribute to Malaysia clinical lab market growth.
It is expected that Malaysia’s clinical lab market to grow at a robust CAGR for the period of 2022P-2027F.
Key Segments Covered
Malaysia Clinical Lab Market:
- By Type of Lab
- Organized Labs
- Unorganized Labs
- By Type of Ownership
- Private
- Public
- By Mode of Tests
- Walk-Ins
- Doctor Referrals
- Corporate Clients
- Online Referrals
- External referrals
- By Type of Tests
- Routine
- Esoteric
- Non-Laboratory
- By Patient’s Age
- 0-20
- 20-40
- 40-60
- 60 and above
Request for Free Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MjQx
- By Region
- West Malaysia
- East Malaysia
- By Payer
- Out of pocket
- Government
- Private insurance
- Corporates
Key Target Audience
- Clinical Lab companies
- Organized Clinical Laboratories
- Unorganized Clinical Laboratories
- Private Hospitals
- Private Equity and Venture Capitalist
- Industry Associations
- Technology providers
- Government Bodies & Regulating Authorities
Time Period Captured in the Report:
- Historical Period: 2017-2022P
- Base Year: 2022P
- Forecast Period: 2022P– 2027F
Ask for Customization @ https://www.kenresearch.com/ask-customization.php?Frmdetails=NTk2MjQx
Companies Covered:
Diagnostics centers
- BP Leader in Health Check
- Pantai Premier Pathology
- Gribbles
- Lablink Medical Lab
- Clinipath
- Pathlab
- Innoquest
Hospitals
- Sunway Medical Centre
- KPJ healthcare
- Park City medical centre
- Gleneagles Hospital
- PANTAI Hospital
Online Healthcare Apps
- Doctor2U medical Portal
- Bookdoc Connect and Unite
- Doctor Anywhere
- Doc2US
- Docquity
Key Topics Covered in the Report
- Executive summary for Malaysia clinical lab market
- Country Overview of Malaysia
- Ecosystem of major entities in Business model of Malaysia clinical lab market
- Timeline of major operating in the Malaysia clinical lab market
- Cross comparison of clinical laboratories market in Malaysia with south-east Asia
- Malaysia Clinical Lab Market
- Value chain analysis of clinical lab market
- Malaysian healthcare system
- Market overview of Malaysia healthcare market
- Malaysia Clinical Lab Market Size, FY’2017-FY'2022P
- Malaysia Clinical Lab Market Segmentation, FY'2022P
- Segmentation by type of labs and ownership, region and by type of test, by patient age, mode of test, by payer
- Industry Analysis
- SWOT analysis of Malaysia clinical lab market
- Trends and development in Malaysia clinical lab market
- Growth driver in Malaysia clinical lab market
- Technological innovation in Malaysia clinical lab market
- Investment scenario in Malaysia clinical lab market
- Issues and challenges in Malaysia clinical lab market
- Government initiatives
- Impact of covid-19 on Malaysia clinical lab market
- Competitive Landscape of Malaysia Clinical Lab Market
- Market Share of Major Players in Malaysia Clinical Lab Market
- Market Positioning of Major Players in Malaysia Clinical Lab Market
- Gartner Magic Quadrant
- Cross-Comparison of Major Players in Malaysia Clinical Lab Market
- Future Outlook for Market Size and Segmentation, FY’22P-FY’27F
For more information on the research report, refer to below link:
Malaysia Clinical Lab Market Outlook to 2027F: Ken Research
Related Reports
Philippines Clinical Lab Market Outlook to 2027F
Indonesia Clinical Lab Market Outlook to 2026F (Second Edition)
No comments:
Post a Comment